Cardax Inc
OTC:CDXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cardax Inc
OTC:CDXI
|
US |
|
W
|
Whoosh Holding PAO
MOEX:WUSH
|
RU |
|
B
|
Banco Santander Chile
F:BSA
|
CL |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Cardax Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cardax Does
Cardax, Inc. is a development stage biopharmaceutical company, which engages in development of pharmaceuticals for chronic diseases driven by inflammation. The company is headquartered in Honolulu, Hawaii and currently employs 10 full-time employees. The company went IPO on 2012-01-30. The firm markets ZanthoSyn, an astaxanthin dietary supplement for lifespan and health span (inflammatory health), including joint and muscle function, cognitive performance, and cardiovascular health.
- Headquarters
- United States of America US
- Employees
- 10
- IPO date
- Jan 30, 2012